► 11:56 Treatment for CLL, Multiple Myeloma, and NHL Hematology-Oncology @betsyodonnellmd, of @DanaFarber, discusses #treatment for #CLL, #NHL, and #multiplemyeloma.
► 29:27 Best of Hematology Panel Discussion Hematology-Oncology @betsyodonnellmd, of @DanaFarber, moderates a #hematology panel discussion.
► 1:04:43 Cancer Detection and Cancer Institute Discussions Hematology-Oncology @RFitzgerald_lab from @Cambridge_Uni discusses @EarlyCancerCam.
► 3:04 Combination Therapy Options for Blast Phase CML Treatment CML Content Hub @CoplandMhairi, of @UofGlasgow, discusses #combination #therapy for #CML.
► 1:11 Reducing Dosage to Manage Side Effects of Long-Term TKI Use CML Content Hub @CoplandMhairi, of @UofGlasgow, discusses #management of #side effects with long-term #TKI use.
► 06:40 Successful Treatment-Free Remission in Patients With CML After TKI Discontinuation CML Content Hub @FadiHaddad_MD, of @MDAndersonNews, discusses treatment-free remission in #CML.
► 7:06 Timing Discontinuation of Treatment: Critical to Maximize Chances of Successful TFR CML Content Hub @FadiHaddad_MD, of @MDAndersonNews, discusses #treatment #discontinuation in #CML.
► 0:39 Additional Chromosomal Abnormalities in CML: An Indication for Close Monitoring CML Content Hub Susanne Saussele, MD, discusses the importance of #chromosome #abnormalities in #CML.
► 0:59 FLOT2 Deficiency and Prolonged Survival in CML CML Content Hub Daniela Krause, MD, of @goetheuni, discusses #FLOT2 deficiency and #survival in #CML.
► 1:09 Selecting CML Patients Eligible for Treatment Cessation CML Content Hub Susanne Saussele, MD, discusses #treatment #discontinuation in #CML.
